The antiphospholipid syndrome (APS) is an autoimmune thrombophilic condition that is
marked by the presence of antibodies that recognize phospholipid-binding proteins. The …

Anti-phospholipid antibodies (aPL) are risk factor for recurrent pregnancy loss and
obstetrical complications. The mechanisms of aPL-mediated pregnancy failure are still a …

Anti-phospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis
and pregnancy morbidity. It is well known that in these patients thrombosis may be the result …

The description of antiphospholipid syndrome (APS) is vascular thrombosis and/or
pregnancy morbidity occurring in persons with antiphospholipid antibodies (aPL). However …

Atherosclerosis, a major cause of disease and death from cardiovascular disease (CVD), is
an inflammatory disease characterized by T cell and monocyte/macrophage infiltration in the …

Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic
predisposition, immune system malfunction or even backfire, hormonal regulation, and …

Objectives: Thromboembolic episodes are frequent manifestations of systemic lupus
erythematosus (SLE). Although the presence of anti‐phospholipid antibodies (aPL) is known …

The definition of antiphospholipid syndrome (APS), as shown in Box 1, is vascular
thromboses or pregnancy morbidity occurring in persons who have one or more of a family …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
persistent presence of antibodies directed against phospholipids and phospholipid-binding …

The most common acquired thrombophilia is the antiphospholipid syndrome (APS). Nigel
Harris first used the term antiphospholipid syndrome in 1986 1 to refer to what is now a well …